Previous Article | Next Article ![]()
Journal of Clinical Microbiology, August 2009, p. 2611-2615, Vol. 47, No. 8
0095-1137/09/$08.00+0 doi:10.1128/JCM.00278-09
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

tjan J. Kocjan,1
Anja Kovanda,1
Maja M. Lunar,1
Snje
ana
idovec Lepej,2
Ana Planini
,2
Katja Seme,1 and
Adriana Vince2
Institute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Slovenia,1 University Hospital for Infectious Diseases, Zagreb, Croatia2
Received 8 February 2009/ Returned for modification 19 March 2009/ Accepted 26 May 2009
A genotyping study of 285 Hybrid Capture 2 low-risk probe cocktail-positive specimens showed cross-reactivity with several untargeted human papillomavirus genotypes. Cross-reactivity was often clinically beneficial due to the detection of untargeted low-risk genotypes. A total of 8.4% of positive results, usually weak, were due to cross-reactivity with high-risk genotypes. Establishment of a gray zone is recommended.
ka 4, 1000 Ljubljana, Slovenia. Phone: 386 1 543 7453. Fax: 386 1 543 7418. E-mail: mario.poljak{at}mf.uni-lj.si
Published ahead of print on 3 June 2009.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»